The images, gathered during a routine angiogram, are fed into a supercomputer. Within 24 hours, a model of a person’s artery is 3D printed. This gives cardiologists crucial information about the behaviour of blood flow and the precise structure of the artery from the inside.
It also helps them make decisions about the best stent (the device used to hold open a collapsed or blocked artery) to insert.
The technique can also detect ‘hot spots’ for plaque, the waxy substance that builds up in arteries and causes heart disease. Some of these plaques have been difficult to find using traditional techniques.
The potential use of supercomputers for personalised medicine is described in an academic paper published today in the European Heart Journal.
Heart disease remains the number one killer in Australia, affecting one in every six adults.. Every nine minutes, a person suffers a heart attack. New techniques to predict plaque build up in the heart will be essential to reduce this toll.
Lead author, University of Melbourne Associate Professor Peter Barlis, is an interventional cardiologist with St Vincent’s and Northern Hospitals.
“Using our ultrasensitive heart scans combined with models derived using supercomputers, we are now able to print out segments of the patient’s arteries and hope to tailor devices to fit them perfectly,” Assoc Prof Barlis said.
“No two arteries are shaped the same. We’re all different, with arteries that have different branches and sizes, tapering from larger to smaller. And much like debris accumulates along a riverbank, plaque can cling to certain areas of a person’s artery. So this technology really gives us a clearer picture of those areas.
“We ideally want to use models to predict the best type of stent for a patient. Once this process is streamlined, we can have a patient on the table and an artery 3D printed and modeled to guide the procedure.”
Identifying which plaques go on to cause a heart attack remains the ‘holy grail’ of cardiology.
“Using a super-high resolution camera, known as optical coherence tomography (OCT), to scan the insides of the heart arteries has made it easier to image cholesterol plaques, but it still isn’t clear which of these plaques will go on to cause heart attacks.
“If we can identify these high-risk plaques more accurately and much earlier, we may be able to prevent heart attacks before they occur.”
Associate Professor Barlis introduced OCT to Australia in 2009 and has been refining the technology to benefit cardiac patients since. He says 3D modelling has very promising potential to predict where plaques could form and will ultimately help cardiologists predict heart attacks.
Co-author and University of Melbourne researcher Dr Vikas Thondapu says the clues about dangerous cholesterol plaques lie in certain disturbances in blood flow patterns.
“Our work involves using supercomputers to simulate blood flow in the arteries. The goal is to use blood flow patterns and disturbances to potentially predict the future development of high-risk plaques,” Dr Thondapu said.
Assoc Prof Barlis and his team now have two ARC grants to work with the University’s Engineering School, to find a biocompatible polymer to 3D print heart stents to precisely match a person’s physical makeup, reducing the risk of stent collapse or complications.
They are also interested in new polymers that will allow the stent to slowly disintegrate over time and that can deliver drugs directly to the location of the plaque.
The Latest on: Personalised treatment for heart disease
via Google News
The Latest on: Personalised treatment for heart disease
- Want to lower your risk for cardiovascular disease? Try a vegetarian dieton August 16, 2019 at 2:13 pm
A study of 44,500 people in England and Scotland revealed that vegetarians were 32 percent less likely to die or to need hospital treatment as a result of heart disease. The scientists looked at data ...
- Norway company aims to create a device in Twin Cities to treat heart valve diseaseon August 16, 2019 at 12:02 pm
And a medical device startup company called CardioMech is growing operations in Minnesota to create implantable synthetic heartstrings to treat a complex heart condition called degenerative mitral ...
- For Heart Patients, CPAP Treatment May Ease Depression: Studyon August 16, 2019 at 11:35 am
FRIDAY, Aug. 16, 2019 (HealthDay News) -- Continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea can ease depression in people with heart disease, according to a ...
- Ministers are to scrap 'one-size-fits-all' NHS health MOTs for the middle aged and replace them with finely tailored medical checkson August 15, 2019 at 4:01 pm
Health Secretary Matt Hancock said the revamped NHS Health Checks scheme – which is offered to anyone aged 40 to 74 – will harness modern technology such as genetic testing to create a personalised ...
- New target found for disease of the heart's smallest blood vesselson August 12, 2019 at 8:09 am
Like the larger coronary artery problems most of us probably think of when we think of heart disease, factors like high cholesterol ... in turn improved the ability of blood vessels to dilate.
- Structural Heart Disease Treatment Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2026on August 12, 2019 at 12:52 am
Aug 12, 2019 (Brandessence Market Research via COMTEX) -- Brandessenceresearch.biz, has been added a concise study on the Structural Heart Disease Treatment Devices Market to depict valuable insights ...
- Cerner, Duke to Automate Data Collection for Chronic Disease Careon August 9, 2019 at 6:47 am
The pilot project and study will use the Cerner Learning Health Network to bring together data and intelligence to deliver insights to clinicians on chronic cardiovascular disease. If not treated ...
- Global Valvular Heart Disease Treatment Market to Reach $XX.XX Million, Globally, by 2025 at X.XX% CAGRon August 9, 2019 at 12:19 am
Aug 09, 2019 (Aperture Games via COMTEX) -- Global Valvular Heart Disease Treatment Market provided by Fior Markets offers a deep insight into the global Valvular Heart Disease Treatment market ...
- New study sheds light on novel exercise treatment for common form of cardiovascular diseaseon August 7, 2019 at 5:27 am
we would have never known about the heart disease," Dr. Parmenter says. Now, the researchers hope that their findings will soon be reflected in treatment guidelines for PAD. "The evidence is now ...
- Half of patients on statins fail to reach 'healthy' cholesterol level after 2 yearson April 16, 2019 at 6:07 am
The findings back up those of previous studies, and highlight the need for personalised medicine to tackle ... cholesterol level after 2 years: Tailored treatment needed to stave off heightened heart ...
via Bing News